Sarepta’s moved full gene therapy over ASO’s with i think 5 deals over the last year phylogica is obviously hoping they can deliver sonething they want next year - always seem to be chasing their tails though - i hope in 6 -12 months time we get the data on either ASO’s or Crispr and it’s not vanishing in favour of the “big new lead” and headline target.
Ann: Successful Delivery of CRIPR/Cas9 into Cells ex vivo, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |